Cancer Medicines Forum: kick-off meeting
This first meeting of EMA's Cancer Medicines Forum looked at challenges around research into optimising cancer treatments. These included dose-optimisation and similar approaches tailored to the characteristics of the patient and the disease.
The CMF aims to explore how EMA can contribute towards addressing remaining uncertainties about the use of cancer medicines in clinical practice.
The meetings of the forum are by invitation only.
EMA launched the CMF together with the European Organisation for Research and Treatment of Cancer (EORTC) in March 2022.
EMA will review the composition and procedures of the forum after a one-year pilot phase.